Evidence map›Paper›PMID 35362784›Full record

ReviewCurrent genetics2022

How adaptive laboratory evolution can boost yeast tolerance to lignocellulosic hydrolyses.

Yasmine Alves Menegon, Jeferson Gross, Ana Paula Jacobus

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. TuningJournal of fungi (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Adaptive laboratory evolution ofFood chemistry: X · 2025
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. An Evolved Strain of the Oleaginous YeastJournal of fungi (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yasmine Alves Menegon *Institute for Bioenergy Research, São Paulo State University (UNESP), Rio Claro, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-0871-7300
Jeferson Gross *Institute for Bioenergy Research, São Paulo State University (UNESP), Rio Claro, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-4537-2946
Ana Paula JacobusInstitute for Bioenergy Research, São Paulo State University (UNESP), Rio Claro, São Paulo, Brazil. ana.jacobus@unesp.br.ORCID http://orcid.org/0000-0002-9092-931X

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2017/24453-5
6 · The paper itself

Abstract

The yeast Saccharomyces cerevisiae is an excellent candidate for establishing cell factories to convert lignocellulosic biomass into chemicals and fuels. To enable this technology, yeast robustness must be improved to withstand the fermentation inhibitors (e.g., weak organic acids, phenols, and furan aldehydes) resulting from biomass pretreatment and hydrolysis. Here, we discuss how evolution experiments performed in the lab, a method commonly known as adaptive laboratory evolution (ALE), may contribute to lifting yeast tolerance against the inhibitors of lignocellulosic hydrolysates (LCHs). The key is that, through the combination of whole-genome sequencing and reverse engineering, ALE provides a robust platform for discovering and testing adaptive alleles, allowing to explore the genetic underpinnings of yeast responses to LCHs. We review the insights gained from past evolution experiments with S. cerevisiae in LCH inhibitors and propose experimental designs to optimise the discovery of genetic variants adaptive to biomass toxicity. The knowledge gathered through ALE projects is envisaged as a roadmap to engineer superior yeast strains for biomass-based bioprocesses.

Indexed as

EthanolSaccharomyces cerevisiaeFermentationHydrolysisLigninEthanolLigninlignocelluloseAdaptive laboratory evolutionLignocellulosic hydrolysatesMolecular geneticsSaccharomyces cerevisiaeSecond-generation ethanol

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.